PVA TePla America forms global strategic partnership with Integrated Surface Technologies

NewsGuard 100/100 Score

PVA TePla America, Inc.(PTA), a subsidiary of PVA TePla AG (DAX: TPE) announced today it has formed a global strategic alliance with Integrated Surface Technologies (IST) MENLO PARK, CA. The alliance will leverage the global sales, contract services, field service and development resources of PTA and IST's silane surface chemistry technologies as well as atomic layer deposition techniques. IST's technology focuses on nano-scale (1 x 10−9 m) surface modification films used in the MEMS, BIO-MEMS, Semi, Microarray and Micro fluidics markets. The IST technology complements PTA's Plasma technology for sub-micron (<1×10−6 m) scale Plasma Enhanced Chemical Vapor Deposition (PECVD) coatings popular in the Medical, Life Sciences, Electronics and Industrial sectors.

IST's founder, Jeff Chinn, Ph.D., has co-authored over 100 technical publications and has 76 issued US patents. He founded Integrated Surface Technologies (IST) in 2007 to develop systems and processes that provide water protection for electronic components by applying nano-composite coatings on consumer electronic devices. Dr. Chinn previously founded Applied Microstructures (AMST), a surface engineering company focused on molecular vapor deposited films. Under his leadership the company sold 45 systems for MEMS, medical and life science applications. Dr Chinn is a veteran of the semiconductor industry with over 25 years experience; he was the General Manager of the MEMS Business Group at Applied Materials where he headed an internal start-up dedicated to the development of processing equipment for the MEMS industry.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Azenta opens the doors to its new genomics laboratory in Oxford, UK